Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Galera Therapeutics Inc
GRTXCurrent price
0.12 USD
0 USD (0.00%)
Last closed
0.12 USD
Company
www.galeratx.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
6 998 100 USD
Yield for 12 month
-94.94 %
1Y
3Y
5Y
10Y
15Y
GRTX
Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and for patients with HNC undergoing standard-of-care radiotherapy. It also develops rucosopasem manganese (rucosopasem) to augment the anti-cancer efficacy of stereotactic body radiation therapy in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is based in Malvern, Pennsylvania. Address: P.O. Box 134, Malvern, PA, United States, 19355
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.5 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+88 000 USD
Current Year
-259 000 USD
Last Year
-114 000 USD
Current Quarter
-9 000 USD
Last Quarter
-127 000 USD
Key Figures GRTX
1 year
3 years
5 years
10 years
EBITDA
-37 399 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-59.29 %
PEG Ratio
–
Return On Equity TTM
-1063.11 %
Wall Street Target Price
0.5 USD
Revenue TTM
–
Book Value
-2.48 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.91 USD
Diluted Eps TTM
-0.91 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics GRTX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GRTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation GRTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.1763
Price Book MRQ
29.3902
Financials GRTX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GRTX
For 52 weeks
0.065 USD
2.74 USD
50 Day MA
0.14 USD
Shares Short Prior Month
2 793 016
200 Day MA
0.17 USD
Short Ratio
1.16
Shares Short
2 123 783
Short Percent
5.28 %
BeatStart